Elevate Anti Dandruff
NDC Package 83830-107-01
Package Information
Elevate Anti Dandruff is a . Marketed by Foshan Yilai Cosmetics Co., Ltd., this product is identified by NDC 83830-107 and is authorized under FDA application M032.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83830 - Foshan Yilai Cosmetics Co., Ltd.
- 83830-107 - Elevate Anti Dandruff
- 83830-107-01 - 250 mL in 1 BOTTLE, PUMP
- 83830-107 - Elevate Anti Dandruff
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83830-107-01 identifies a specific commercial package of 250 ml in 1 bottle, pump of Elevate Anti Dandruff, labeled by Foshan Yilai Cosmetics Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Foshan Yilai Cosmetics Co., Ltd. on January 25, 2024. The current certification is valid through March 07, 2024.
How is this Foshan Yilai Cosmetics Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83830010701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.